In this issue:
Anti-staphylococcal β-lactam + standard treatment for MRSA
Inhaled amikacin in ventilated Gram-negative pneumonia patients
Trends in US burden of Clostridioides difficile infection
Oral influenza vaccine
Multidrug-resistant bacterial infections in the US
Meningococcal B vaccine in Australian adolescents
COVID-19 in immune-mediated inflammatory diseases
Treatment of highly drug-resistant pulmonary tuberculosis
Long-acting cabotegravir + rilpivirine after oral induction for HIV-1
Long-acting cabotegravir + rilpivirine for HIV-1 suppression maintenance
Please login below to download this issue (PDF)